Saratoga Research & Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $790K | Sell |
2,181
-125
| -5% | -$42.8K | 0.04% | 33 |
|
|
2026
Q1 | $811K | Sell |
2,306
-52
| -2% | -$18.5K | 0.05% | 30 |
|
|
2025
Q4 | $772K | Hold |
2,358
| – | – | 0.04% | 37 |
|
|
2025
Q3 | $665K | Hold |
2,358
| – | – | 0.03% | 35 |
|
|
2025
Q2 | $658K | Buy |
2,358
+40
| +2% | +$11.3K | 0.04% | 37 |
|
|
2025
Q1 | $722K | Hold |
2,318
| – | – | 0.04% | 33 |
|
|
2024
Q4 | $604K | Sell |
2,318
-208
| -8% | -$61.7K | 0.03% | 35 |
|
|
2024
Q3 | $814K | Hold |
2,526
| – | – | 0.04% | 33 |
|
|
2024
Q2 | $789K | Sell |
2,526
-47
| -2% | -$13.8K | 0.04% | 33 |
|
|
2024
Q1 | $732K | Sell |
2,573
-167
| -6% | -$48.9K | 0.03% | 35 |
|
|
2023
Q4 | $789K | Sell |
2,740
-33,169
| -92% | -$9.04M | 0.04% | 38 |
|
|
2023
Q3 | $9.65M | Buy |
35,909
+126
| +0.4% | +$31.4K | 0.47% | 31 |
|
|
2023
Q2 | $7.94M | Buy |
35,783
+264
| +0.7% | +$61.3K | 0.37% | 32 |
|
|
2023
Q1 | $8.59M | Buy |
35,519
+258
| +0.7% | +$63.3K | 0.41% | 32 |
|
|
2022
Q4 | $9.26M | Sell |
35,261
-2,366
| -6% | -$634K | 0.46% | 31 |
|
|
2022
Q3 | $8.48M | Sell |
37,627
-2,683
| -7% | -$650K | 0.45% | 31 |
|
|
2022
Q2 | $9.81M | Sell |
40,310
-570
| -1% | -$140K | 0.49% | 31 |
|
|
2022
Q1 | $9.89M | Hold |
40,880
| – | – | 0.43% | 31 |
|
|
2021
Q4 | $9.2M | Buy |
40,880
+4,829
| +13% | +$1.02M | 0.39% | 30 |
|
|
2021
Q3 | $7.67M | Buy |
36,051
+6,235
| +21% | +$1.44M | 0.35% | 31 |
|
|
2021
Q2 | $7.27M | Buy |
29,816
+1,256
| +4% | +$309K | 0.34% | 31 |
|
|
2021
Q1 | $7.11M | Buy |
28,560
+1,556
| +6% | +$371K | 0.36% | 32 |
|
|
2020
Q4 | $6.21M | Sell |
27,004
-54
| -0.2% | -$12.4K | 0.33% | 31 |
|
|
2020
Q3 | $6.88M | Sell |
27,058
-721
| -3% | -$179K | 0.41% | 31 |
|
|
2020
Q2 | $6.55M | Buy |
27,779
+615
| +2% | +$140K | 0.41% | 31 |
|
|
2020
Q1 | $5.51M | Buy |
27,164
+4,905
| +22% | +$1.07M | 0.38% | 29 |
|
|
2019
Q4 | $5.37M | Buy |
22,259
+2,217
| +11% | +$489K | 0.32% | 29 |
|
|
2019
Q3 | $3.88M | Buy |
20,042
+930
| +5% | +$179K | 0.25% | 29 |
|
|
2019
Q2 | $3.52M | Buy |
19,112
+5,969
| +45% | +$1.07M | 0.22% | 29 |
|
|
2019
Q1 | $2.5M | Buy |
13,143
+2,600
| +25% | +$497K | 0.17% | 28 |
|
|
2018
Q4 | $2.05M | Buy |
10,543
+1,322
| +14% | +$258K | 0.16% | 29 |
|
|
2018
Q3 | $1.91M | Buy |
9,221
+1,990
| +28% | +$392K | 0.13% | 29 |
|
|
2018
Q2 | $1.33M | Buy |
7,231
+2,769
| +62% | +$490K | 0.1% | 29 |
|
|
2018
Q1 | $761K | Buy |
+4,462
| New | +$819K | 0.06% | 29 |
|
Other funds holding AMGN
Saratoga Research & Investment Management's AMGN Position: Q2 2026 in Review
Saratoga Research & Investment Management reduced its Amgen (AMGN) stake by 5.4% in Q2 2026, selling an estimated $42.8K and leaving 2,181 shares worth $790K. The position accounts for 0.04% of the portfolio, ranked #33.
Saratoga Research & Investment Management first reported a position in AMGN in Q1 2018 and has held it in 34 quarters since. The position peaked at $9.89M in Q1 2022. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Saratoga Research & Investment Management held 2,181 shares of Amgen worth $790K as of Q2 2026.
- Saratoga Research & Investment Management sold 125 Amgen shares in Q2 2026, an estimated $42.8K.
- Amgen made up 0.04% of Saratoga Research & Investment Management's portfolio in Q2 2026, its #33 holding.
- Saratoga Research & Investment Management first reported a position in Amgen in Q1 2018 and has held it in 34 quarters since.
- Saratoga Research & Investment Management's Amgen position peaked at $9.89M in Q1 2022.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Saratoga Research & Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.